Randi Johnson
Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Islets of Langerhans | 14 | 2026 | 852 | 2.710 |
Why?
| | Autoimmunity | 18 | 2026 | 925 | 2.530 |
Why?
| | Diabetes Mellitus, Type 1 | 24 | 2026 | 3930 | 2.230 |
Why?
| | DNA Methylation | 10 | 2026 | 725 | 2.060 |
Why?
| | Seroconversion | 3 | 2026 | 48 | 1.250 |
Why?
| | Nasal Mucosa | 3 | 2025 | 112 | 1.210 |
Why?
| | Asthma | 5 | 2025 | 1800 | 1.190 |
Why?
| | Diet | 6 | 2021 | 1273 | 1.000 |
Why?
| | Genetic Predisposition to Disease | 8 | 2025 | 2488 | 0.900 |
Why?
| | Autoantibodies | 8 | 2026 | 1500 | 0.870 |
Why?
| | Metabolomics | 4 | 2024 | 738 | 0.680 |
Why?
| | Dinoprostone | 1 | 2022 | 179 | 0.680 |
Why?
| | B-Lymphocytes | 1 | 2026 | 887 | 0.640 |
Why?
| | Neutrophils | 1 | 2026 | 1133 | 0.630 |
Why?
| | Quantitative Trait Loci | 2 | 2021 | 388 | 0.620 |
Why?
| | Gene Expression Regulation | 3 | 2025 | 2599 | 0.620 |
Why?
| | Lipid Metabolism | 2 | 2024 | 533 | 0.610 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2021 | 178 | 0.580 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2019 | 102 | 0.570 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2025 | 1150 | 0.560 |
Why?
| | Adolescent Health | 1 | 2019 | 38 | 0.560 |
Why?
| | Case-Control Studies | 9 | 2026 | 3647 | 0.560 |
Why?
| | Biological Specimen Banks | 3 | 2026 | 137 | 0.560 |
Why?
| | Glutens | 4 | 2021 | 57 | 0.490 |
Why?
| | Child, Preschool | 17 | 2026 | 11913 | 0.460 |
Why?
| | Schools | 1 | 2019 | 436 | 0.460 |
Why?
| | Child | 22 | 2026 | 22693 | 0.440 |
Why?
| | Sexual Behavior | 1 | 2019 | 490 | 0.420 |
Why?
| | Risk Factors | 12 | 2025 | 10921 | 0.420 |
Why?
| | Precision Medicine | 3 | 2023 | 462 | 0.410 |
Why?
| | Adolescent Behavior | 1 | 2019 | 486 | 0.400 |
Why?
| | Rural Population | 1 | 2019 | 677 | 0.400 |
Why?
| | Female | 32 | 2026 | 79499 | 0.390 |
Why?
| | Health Behavior | 1 | 2019 | 802 | 0.380 |
Why?
| | Male | 27 | 2026 | 73396 | 0.360 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2023 | 2623 | 0.360 |
Why?
| | Humans | 40 | 2026 | 146342 | 0.340 |
Why?
| | Epigenesis, Genetic | 4 | 2026 | 712 | 0.340 |
Why?
| | Vitamin D | 2 | 2026 | 402 | 0.300 |
Why?
| | Disease Progression | 5 | 2026 | 2867 | 0.290 |
Why?
| | Eating | 3 | 2021 | 386 | 0.290 |
Why?
| | CpG Islands | 3 | 2023 | 175 | 0.270 |
Why?
| | Follow-Up Studies | 5 | 2026 | 5439 | 0.260 |
Why?
| | Adolescent | 12 | 2026 | 22557 | 0.250 |
Why?
| | Colorado | 5 | 2026 | 4595 | 0.250 |
Why?
| | Celiac Disease | 2 | 2020 | 285 | 0.240 |
Why?
| | Genome-Wide Association Study | 3 | 2024 | 1537 | 0.240 |
Why?
| | Biomarkers | 4 | 2026 | 4340 | 0.220 |
Why?
| | HLA Antigens | 1 | 2026 | 241 | 0.210 |
Why?
| | Tacrolimus Binding Proteins | 1 | 2024 | 25 | 0.210 |
Why?
| | Pedigree | 1 | 2025 | 512 | 0.200 |
Why?
| | Information Dissemination | 1 | 2026 | 226 | 0.200 |
Why?
| | Genetics, Population | 1 | 2025 | 226 | 0.200 |
Why?
| | Multifactorial Inheritance | 1 | 2025 | 243 | 0.200 |
Why?
| | Diet Surveys | 2 | 2021 | 89 | 0.200 |
Why?
| | Oxylipins | 2 | 2023 | 47 | 0.200 |
Why?
| | Pregnancy | 6 | 2025 | 7230 | 0.190 |
Why?
| | GTPase-Activating Proteins | 1 | 2023 | 81 | 0.190 |
Why?
| | Proportional Hazards Models | 3 | 2021 | 1331 | 0.180 |
Why?
| | Prognosis | 3 | 2026 | 4351 | 0.180 |
Why?
| | Infant | 9 | 2026 | 10114 | 0.180 |
Why?
| | Transcriptome | 2 | 2025 | 1068 | 0.170 |
Why?
| | Eicosanoids | 1 | 2022 | 58 | 0.170 |
Why?
| | Motivation | 1 | 2026 | 605 | 0.170 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2021 | 49 | 0.170 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2025 | 665 | 0.160 |
Why?
| | Gene Expression | 1 | 2025 | 1463 | 0.160 |
Why?
| | Pregnancy Trimester, Third | 1 | 2021 | 117 | 0.160 |
Why?
| | Breast Feeding | 2 | 2021 | 447 | 0.160 |
Why?
| | Dietary Sucrose | 1 | 2020 | 49 | 0.150 |
Why?
| | Sugars | 1 | 2020 | 40 | 0.150 |
Why?
| | Smoking | 2 | 2025 | 1486 | 0.150 |
Why?
| | Nerve Tissue Proteins | 1 | 2023 | 597 | 0.150 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2021 | 159 | 0.150 |
Why?
| | Phospholipids | 1 | 2021 | 215 | 0.150 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2021 | 2240 | 0.150 |
Why?
| | Early Diagnosis | 1 | 2019 | 251 | 0.140 |
Why?
| | Thinness | 1 | 2019 | 100 | 0.140 |
Why?
| | Gene Expression Profiling | 1 | 2025 | 1792 | 0.140 |
Why?
| | Pregnancy in Adolescence | 1 | 2019 | 78 | 0.140 |
Why?
| | Dietary Proteins | 1 | 2019 | 135 | 0.140 |
Why?
| | Prospective Studies | 5 | 2023 | 8123 | 0.130 |
Why?
| | Postpartum Period | 1 | 2021 | 377 | 0.130 |
Why?
| | Chromatography, Liquid | 1 | 2019 | 453 | 0.130 |
Why?
| | Guatemala | 1 | 2019 | 349 | 0.130 |
Why?
| | Vulnerable Populations | 1 | 2019 | 178 | 0.130 |
Why?
| | Child Health | 1 | 2019 | 153 | 0.130 |
Why?
| | Health Surveys | 1 | 2019 | 511 | 0.120 |
Why?
| | Child Behavior | 1 | 2019 | 234 | 0.120 |
Why?
| | Risk-Taking | 1 | 2019 | 321 | 0.120 |
Why?
| | Pilot Projects | 1 | 2022 | 1888 | 0.120 |
Why?
| | Longitudinal Studies | 4 | 2026 | 3017 | 0.120 |
Why?
| | Environmental Exposure | 1 | 2020 | 578 | 0.110 |
Why?
| | Pregnancy, Unplanned | 1 | 2015 | 48 | 0.110 |
Why?
| | Diabetes Mellitus | 1 | 2023 | 1101 | 0.110 |
Why?
| | Infant, Low Birth Weight | 1 | 2015 | 154 | 0.100 |
Why?
| | Contraceptive Agents, Female | 1 | 2015 | 80 | 0.100 |
Why?
| | Overweight | 1 | 2019 | 614 | 0.100 |
Why?
| | Safety-net Providers | 1 | 2015 | 133 | 0.100 |
Why?
| | Adult | 8 | 2026 | 41087 | 0.100 |
Why?
| | Pandemics | 1 | 2022 | 1707 | 0.100 |
Why?
| | Students | 1 | 2019 | 649 | 0.100 |
Why?
| | Young Adult | 4 | 2026 | 14330 | 0.090 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5899 | 0.090 |
Why?
| | Health Promotion | 1 | 2019 | 786 | 0.090 |
Why?
| | Aged | 2 | 2023 | 26432 | 0.090 |
Why?
| | Infant, Newborn | 2 | 2021 | 6460 | 0.090 |
Why?
| | Pediatrics | 1 | 2020 | 1124 | 0.090 |
Why?
| | Premature Birth | 1 | 2015 | 390 | 0.080 |
Why?
| | Insulin | 1 | 2020 | 2525 | 0.070 |
Why?
| | Genotype | 2 | 2026 | 1879 | 0.070 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 6073 | 0.060 |
Why?
| | Incidence | 2 | 2026 | 2936 | 0.060 |
Why?
| | Age of Onset | 1 | 2026 | 558 | 0.050 |
Why?
| | Fibronectins | 1 | 2024 | 136 | 0.050 |
Why?
| | Haplotypes | 1 | 2025 | 506 | 0.050 |
Why?
| | Focus Groups | 1 | 2026 | 588 | 0.050 |
Why?
| | Cohort Studies | 2 | 2026 | 6077 | 0.050 |
Why?
| | Gene Regulatory Networks | 1 | 2024 | 319 | 0.040 |
Why?
| | Ascorbic Acid | 1 | 2023 | 183 | 0.040 |
Why?
| | Epidemiologic Studies | 1 | 2021 | 70 | 0.040 |
Why?
| | Metabolome | 1 | 2024 | 390 | 0.040 |
Why?
| | Origin of Life | 1 | 2020 | 8 | 0.040 |
Why?
| | Iodide Peroxidase | 1 | 2020 | 34 | 0.040 |
Why?
| | Isotopes | 1 | 2020 | 33 | 0.040 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 47 | 0.040 |
Why?
| | HLA-DR4 Antigen | 1 | 2020 | 74 | 0.040 |
Why?
| | HLA-DR3 Antigen | 1 | 2020 | 76 | 0.040 |
Why?
| | Peroxidase | 1 | 2020 | 168 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2023 | 731 | 0.040 |
Why?
| | Fetal Blood | 1 | 2021 | 325 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2021 | 752 | 0.040 |
Why?
| | Machine Learning | 1 | 2025 | 594 | 0.040 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 145 | 0.040 |
Why?
| | GTP-Binding Proteins | 1 | 2019 | 150 | 0.040 |
Why?
| | Middle Aged | 3 | 2026 | 36619 | 0.040 |
Why?
| | Transglutaminases | 1 | 2019 | 137 | 0.040 |
Why?
| | Gene Frequency | 1 | 2020 | 496 | 0.030 |
Why?
| | Interleukins | 1 | 2020 | 248 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2020 | 379 | 0.030 |
Why?
| | Collagen | 1 | 2020 | 460 | 0.030 |
Why?
| | Algorithms | 1 | 2025 | 1849 | 0.030 |
Why?
| | Calcium | 1 | 2023 | 1181 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 444 | 0.030 |
Why?
| | Gestational Age | 1 | 2020 | 990 | 0.030 |
Why?
| | Pediatric Obesity | 1 | 2024 | 635 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2022 | 844 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2019 | 576 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2024 | 1247 | 0.030 |
Why?
| | Self Report | 1 | 2020 | 870 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2015 | 192 | 0.030 |
Why?
| | Family Planning Services | 1 | 2015 | 93 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2015 | 503 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2015 | 1327 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 2015 | 1107 | 0.020 |
Why?
| | Mice | 1 | 2022 | 18297 | 0.010 |
Why?
| | Animals | 1 | 2022 | 38106 | 0.010 |
Why?
|
|
Johnson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|